Leanne Male, Assistant Director of Research, Asthma UK says: 'This study adds to previous research which shows that a Mediterranean diet, which traditionally contains higher levels of fresh fruit and vegetables, can have a beneficial effect on asthma symptoms and specifically in this study that these benefits can be passed onto the pregnant mother's unborn child.
This supports our advice to pregnant mothers to eat a healthy, balanced diet and is of particular significance to mothers in the UK as we have one of the highest rates of childhood asthma worldwide, with one in ten children suffering from the condition.
Notes
1. Asthma UK is the charity dedicated to improving the health and well-being of the 5.2 million people in the UK whose lives are affected by asthma. Asthma UK Scotland is dedicated to improving the health and well-being of the 390,000 people in Scotland whose lives are affected by asthma.
2. For up-to-date news on asthma, information and publications, visit the Asthma UK website http://www.asthma.org.uk.
3. For independent and confidential advice on asthma, call the Asthma UK Adviceline, which is staffed by asthma nurse specialists. It is open weekdays from 9am to 5pm on 08457 01 02 03. Or email an asthma nurse at http://www.asthma.org.uk/adviceline.
http://www.asthma.org.uk
Jan 17, 2008
Mediterranean Diet During Pregnancy Helps To Ward Off Childhood Asthma And Allergy
เขียนโดย Pramuk ที่ 04:57 0 ความคิดเห็น
Scientists From 16 Different Countries Study The Link Between Children's Nutrition And The Development Of Adult Diseases Such As Diabetes Or Allergies
Researchers from the Department of Pediatrics of the University of Granada, in collaboration with another 38 universities and companies from 16 European countries, will study the effects of children's nutrition on the onset of cardiovascular problems, diabetes, obesity, allergies, weak bones, neuromotor functioning and children's behavioural aspects. The EARNEST project (The Early Nutrition Programming Project) aims to help in the development of policies, information campaigns, documents, guides and recommendations on the nutritional components of children's food, for the improvement of children's formulas. It also collaborates in the design of plans preventing and avoiding nutrition effects on the metabolism.
Thanks to this project, the University of Granada becomes the only Spanish investigation centre taking part in this ambitious initiative, the first of its kind in Europe. Cristina Campoy Folgoso, the professor heading this initiative in Granada, emphasizes that the "early nutrition programming" is quite a recent subject in the health and science field today. "Different studies show how food can have long-term consequences in children's growth and health during pregnancy, the breastfeeding period and childhood. Moreover, food can also have influence over the later onset of diseases", states the researcher.
Study of disease
This project aims to answer the question about the extent of nutrition effects of prenatal, postnatal, and infant diets of someone among the current European population in critical periods of development as well as the efficiency of actions preventing and avoiding long, medium and short-term metabolic effects on health.
The project will tackle randomly assigned clinical tests and nutritional interventions during pregnancy and childhood, pilot studies, tests on animals, cells and genomita, as well as social and economic studies connected with nutrition in the first stages of life and their significance in the development of later diseases.
The researchers hope to find the genetic mechanism of diseases such as diabetes and obesity with this project. "Obesity, a growing global epidemic, begins, partly, during child development explains professor Campoy Folgoso-. It is known that breastfed children's growth kinetics differ from those fed with commercial foods. These children easily gain weight and height. Considering these consequences, linked with eating habits, the purpose of this project is to study whether breastfeeding can prevent a later risk of obesity.
About EARNEST
This investigation project is financed by the European Commission and is made up of 38 multidisciplinary groups of professionals from 16 European countries. Scientists from different institutions of all over Europe are involved in it: 33 academic institutions, 5 industries and 7 PYMES companies form the project, coordinated by Ludwig Maximilians University in Munich (Germany). It began in April 2005 and will last until 2010.
Coordinator: Professor Berthold Koletzko. Dr. von Hauner Children's Hospital, Ludwig-Maximilians. Ludwig-Maximilians Universty, Munich, Germany.
Institutions taking part: Medical Research Council-Institute of Child Health (London, United Kingdom); University of Pécs (Pécs, Hungary); University of Granada (Spain); University of London-Alliance (United Kingdom); Danish Epidemiology Science Centre (Copenhagen, Denmark); Aarhus University (Denmark); Instituto municipal de Investigació Médica (Barcelona, Spain); Inst of Public Health (Oslo, Norwich); University of Bristol Alliance (United Kingdom); The Children's Memorial Health Institute (Warsaw, Poland); GSF National Research Centre for Environment and Health (Germany); University Hospital Groningen (Holland); Turku University Central Hospital (Turku, Finland); University of Nottingham (United Kingdom); Louvain Universities Alliance (Belgium); Rowett Research Institute (Scotland, United Kingdom); University of Cambridge (United Kingdom); Research Institute for the Biology of Farm Animals (Germany); Centre National de la Recherche Scientifique (France); INSERM (Paris, France); RIVM National Institute for Public Health and the Environment (Holland); Institute of Physiology (Prague, Czech Republic); University Medical Centre (Utrecht, Holland); University of Surrey (United Kingdom).
Companies: DNA testing Ltd (Scotland, United Kingdom); Schothorst Feed Research (Holland); Ashwell Associates (United Kingdom); RDE Software GmbH (Munich, Germany); Institute for Market Research, Strategy and Planning (Munich, Germany); Arexis (Gothenburg, Sweden); BioScientifica, (Bristol, United Kingdom).
Industry: Numico (Friedrichsdorf, Germany); Ordesa, (Spain); Orafti (Belgium); Mead Johnson (USA); Nestlé International.
UNIVERSITY OF GRANADA COMMUNICATIONS DEPARTMENT
Secretariado de Comunicación Universidad de Granada
Hospital Real - Cuesta del Hospicio s/n
http://www.ugr.es
เขียนโดย Pramuk ที่ 04:46 1 ความคิดเห็น
Frostbite, How to deal ?
Frostbite is damage to the skin and underlying tissues resulting from exposure to extreme cold. Frostbitten skin appears hard and pale, and is cold to the touch. The patient may experience lack of sensitivity or numbness in the frostbitten flesh. But as the flesh thaws, it often becomes red and painful. Every part of the body is vulnerable to damage from frostbite. However, it most often occurs on the hands, feet, nose and ears. It can occur whenever tissues are exposed to temperatures below freezing (32 degrees Fahrenheit or 0 degrees Celsius) for extended periods of time. The colder the temperature, the faster the exposed skin can become frostbitten. In fact, skin can become frostbitten in just a few minutes if the temperature is low enough. The presence of wind or wet clothing exacerbates the potential for frostbite because both conditions cause the body to lose heat more rapidly. Frostbite occurs when the body responds to freezing temperatures by redirecting blood (and its nutrients) away from the skin and toward vital organs. It does this by first constricting (narrowing) the blood vessels. Eventually, the body tries to preserve as much function in the extremities (areas farthest from the heart) by promoting a cycle of widening (dilation) and constriction of the blood vessels there. However, once the body temperature sinks to the point that it is in danger of becoming abnormally low (hypothermia), the cycle of widening and constriction ceases, and the blood vessels permanently constrict. Though this prevents cold blood from reaching the internal organs, it also begins the process of frostbite. Frostbite itself is a two-part process: Toxic substances may also be released into the bloodstream as tissues warm. This can lead to irregular heart rhythms (arrhythmias) that must be closely monitored by a physician. Frostbite appears in one of two forms – superficial or deep. In superficial frostbite (frostnip), the skin is white, waxy or grayish-yellow, and feels cold, hard and numb when touched. However, although the surface skin is stiff, the underlying tissue is soft and pliable when depressed. Deep frostbite is characterized by waxy, pale, solid skin. In some cases, blisters also appear on the skin. Damage that is restricted to the skin and underlying tissues is not usually permanent. However, damage that extends to the blood vessels is likely to be permanent. Death and decay of body tissue (gangrene) sometimes follows. Gangrenous tissue must be removed to prevent it from spreading to adjacent tissues or organs, which may necessitate amputation (surgical removal) of the affected body part.
Treatment options for frostbite
Patients who suspect frostbite should promptly call a physician or other medical personnel and follow the instructions they receive. People who either cannot visit a physician or who choose not to do so should take the following steps:
In addition, patients should be careful to avoid certain actions. These include:
Frostbite that requires medical attention may be treated in several different ways. Anti-inflammatory medications such as ibuprofen may be used to reduce inflammation, whereas antibiotics may be prescribed to help prevent infection. In some cases, certain drugs (such as low-molecular-weight dextrans, heparin or phenoxybenzamine) may be administered intravenously to improve circulation to affected areas of tissue. Finally, a physician may prescribe narcotic pain medications to reduce pain during rewarming of the skin, because this pain can be severe. In severe cases, amputation (surgical removal) of a limb or other body part may be necessary to prevent potentially serious health consequences. This is most likely in conditions where death and decay of body tissue (gangrene) have set in. Gangrenous tissue must be removed (usually by amputation) to prevent its spread to other areas of the body. Because the full extent of frostbite damage is not always immediately apparent, a patient may have to undergo amputation several months after the frostbite occurred. Following treatment, patients may continue to feel a throbbing sensation for weeks or months. Eventually, this will taper to tingling or occasional sensations that resemble electric shocks. The affected area may experience sensitivity to cold, chronic pain, sensory loss or other symptoms for years following the episode of frostbite. Excessive sweating and abnormal nail growth may also occur. Prevention methods for frostbite
|
เขียนโดย Pramuk ที่ 04:40 0 ความคิดเห็น